human | Q5 |
P6178 | Dimensions author ID | 0752407603.69 |
P496 | ORCID iD | 0000-0001-6651-7166 |
P6304 | researchportal.helsinki.fi profile ID | alison-dunning |
P10861 | Springer Nature person ID | 0752407603.69 |
P69 | educated at | University of Lancaster | Q262854 |
P108 | employer | University of Cambridge | Q35794 |
University College London | Q193196 | ||
P734 | family name | Dunning | Q21484695 |
Dunning | Q21484695 | ||
Dunning | Q21484695 | ||
P735 | given name | Alison | Q16154105 |
Alison | Q16154105 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | female | Q6581072 |
Q36016386 | 11q13 is a susceptibility locus for hormone receptor positive breast cancer |
Q35871567 | 19p13.1 is a triple-negative-specific breast cancer susceptibility locus |
Q33848895 | 2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy |
Q57725936 | 334 Predictive Value of Cardiac Computed Tomography and the Impact of Renal Function on All Cause Mortality in Confirm: Coronary Computed Tomography Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry |
Q57920219 | 35th Annual Meeting of the European Association for the Study of Diabetes |
Q56883844 | 35th Annual Meeting of the European Association for the Study of Diabetes : Brussels, Belgium, 28 September-2 October 1999 |
Q46711378 | 4-Aminobiphenyl-hemoglobin adducts and risk of smoking-related disease in never smokers and former smokers in the European Prospective Investigation into Cancer and Nutrition prospective study |
Q36021406 | 7q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium |
Q37169873 | 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium |
Q37005064 | A Common Variant at the 14q32 Endometrial Cancer Risk Locus Activates AKT1 through YY1 Binding |
Q101576446 | A Deep Learning Approach Validates Genetic Risk Factors for Late Toxicity After Prostate Cancer Radiotherapy in a REQUITE Multi-National Cohort |
Q55210146 | A Large Study of Androgen Receptor Germline Variants and Their Relation to Sex Hormone Levels and Prostate Cancer Risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. |
Q92224274 | A Mendelian randomization analysis of circulating lipid traits and breast cancer risk |
Q57306192 | A candidate gene approach to searching for low-penetrance breast and prostate cancer genes |
Q42676622 | A combined analysis of genome-wide association studies in breast cancer |
Q46378338 | A common 8q24 variant in prostate and breast cancer from a large nested case-control study |
Q57250674 | A common coding variant in CASP8 is associated with breast cancer risk |
Q35755874 | A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer |
Q45181384 | A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability |
Q33980349 | A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians |
Q24314996 | A gene (DLG2) located at 17q12-q21 encodes a new homologue of the Drosophila tumor suppressor dIg-A |
Q39200585 | A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity |
Q37332232 | A genome-wide association scan (GWAS) for mean telomere length within the COGS project: identified loci show little association with hormone-related cancer risk |
Q34613513 | A genome-wide association scan on estrogen receptor-negative breast cancer |
Q29417036 | A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age. |
Q50104901 | A genome-wide association study to identify genetic markers associated with endometrial cancer grade. |
Q34113217 | A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium |
Q37619303 | A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium |
Q35089479 | A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population |
Q36435849 | A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. |
Q92711687 | A network analysis to identify mediators of germline-driven differences in breast cancer prognosis |
Q35699278 | A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma |
Q71735471 | A polymorphic stop codon in BRCA2 |
Q35870483 | A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients |
Q61560753 | A postulated phylogenetic tree for the human apolipoprotein B gene: Unpredicted haplotypes are associated with elevated apo B levels |
Q34286293 | A replicated association between polymorphisms near TNFα and risk for adverse reactions to radiotherapy |
Q37599352 | A role for XRCC2 gene polymorphisms in breast cancer risk and survival |
Q33766628 | A systematic review of genetic polymorphisms and breast cancer risk. |
Q42208433 | A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1. |
Q57305942 | A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer |
Q44443237 | A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer. |
Q57726025 | ABSENCE OF CORONARY ARTERY CALCIUM DOES NOT FULLY EXCLUDE OBSTRUCTIVE CORONARY ARTERY DISEASE AND FUTURE ADVERSE EVENTS AMONG PATIENTS REFERRED FOR CARDIAC CT ANGIOGRAPHY: RESULTS FROM 17,528 PATIENTS IN THE CONFIRM REGISTRY (CORONARY CT ANGIOGRAPHY |
Q56435657 | Abstract 20: POT1 mutations predispose to familial melanoma |
Q64458508 | Abstract 5493: Genome-wide study of carboplatin and paclitaxel disposition in ovarian cancer patients |
Q39437211 | Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers |
Q46931916 | Air pollution and risk of lung cancer in a prospective study in Europe |
Q46586463 | Allelic association of the human homologue of the mouse modifier Ptprj with breast cancer |
Q57037855 | Amount of DNA in plasma and cancer risk: A prospective study |
Q57278931 | An autosome-wide scan for linkage disequilibrium-based association in sporadic breast cancer cases in eastern Finland: three candidate regions found |
Q61560794 | Apolipoprotein B gene polymorphisms, lipoproteins and coronary atherosclerosis: A study of young myocardial infarction survivors and healthy population-based individuals |
Q35242849 | Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers |
Q34613673 | Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study |
Q90666760 | Assessment of interactions between 205 breast cancer susceptibility loci and 13 established risk factors in relation to breast cancer risk, in the Breast Cancer Association Consortium |
Q35218520 | Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy |
Q57305944 | Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci |
Q45979098 | Association analysis identifies 65 new breast cancer risk loci. |
Q33279162 | Association between common variation in 120 candidate genes and breast cancer risk |
Q43938987 | Association between epitopes detected by monoclonal antibody BIP-45 and the XbaI polymorphism of apolipoprotein B. |
Q37292963 | Association of ESR1 gene tagging SNPs with breast cancer risk |
Q46707380 | Association of a common AKAP9 variant with breast cancer risk: a collaborative analysis |
Q37684672 | Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21. |
Q46943040 | Association of gene variants in the TGF-beta signalling pathways with invasive breast cancer risk. |
Q46935220 | Association of gene variants in the transforming growth factor beta signalling pathways with invasive breast cancer risk. |
Q37268494 | Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry |
Q114182713 | Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment |
Q36593602 | Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population |
Q57306187 | Association of the Progesterone Receptor Gene with Breast Cancer Risk: A Single-Nucleotide Polymorphism Tagging Approach |
Q35934138 | Association studies for finding cancer-susceptibility genetic variants |
Q37151879 | Association study of prostate cancer susceptibility variants with risks of invasive ovarian, breast, and colorectal cancer |
Q57202712 | Associations among Mammographic Density, Circulating Sex Hormones, and Polymorphisms in Sex Hormone Metabolism Genes in Postmenopausal Women |
Q35532898 | Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium |
Q57056093 | Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis |
Q63966080 | Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci |
Q64118820 | Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci |
Q61124964 | Author Correction: Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia |
Q60917552 | Author Correction: Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility |
Q60912720 | Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma |
Q38914005 | BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer |
Q37002955 | BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers |
Q57306056 | BRCA2 arg372hispolymorphism and epithelial ovarian cancer risk |
Q37298148 | Beyond GWASs: illuminating the dark road from association to function |
Q46115524 | Body mass index and breast cancer survival: a Mendelian randomization analysis |
Q100457582 | Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk |
Q34327945 | Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2 |
Q35940158 | Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. |
Q35562912 | Breast cancer susceptibility polymorphisms and endometrial cancer risk: a Collaborative Endometrial Cancer Study |
Q46753298 | Bulky DNA adducts, 4-aminobiphenyl-haemoglobin adducts and diet in the European Prospective Investigation into Cancer and Nutrition (EPIC) prospective study |
Q36449203 | CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer |
Q33994241 | CHEK2, MGMT, SULT1E1 and SULT1A1 polymorphisms and endometrial cancer risk |
Q36419325 | CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer |
Q33616702 | CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium |
Q34180983 | CYP2D6 gene variants and their association with breast cancer susceptibility |
Q21195205 | CYP2D6 gene variants: association with breast cancer specific survival in a cohort of breast cancer patients from the United Kingdom treated with adjuvant tamoxifen |
Q92005489 | Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families |
Q92636519 | Candidate Causal Variants at the 8p12 Breast Cancer Risk Locus Regulate DUSP4 |
Q28385765 | Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk |
Q112645829 | Characterisation of PALB2 tumours through whole-exome and whole-transcriptomic analyses |
Q92475989 | Chromatin interactome mapping at 139 independent breast cancer risk signals |
Q94486442 | Combined associations of a polygenic risk score and classical risk factors with breast cancer risk |
Q73139263 | Common BRCA1 variants and susceptibility to breast and ovarian cancer in the general population |
Q24797594 | Common ERBB2 polymorphisms and risk of breast cancer in a white British population: a case-control study |
Q57265809 | Common Polymorphisms in ERCC2 (Xeroderma pigmentosum D) are not Associated with Breast Cancer Risk |
Q57306188 | Common Variants in RB1 Gene and Risk of Invasive Ovarian Cancer |
Q36856357 | Common genetic determinants of breast-cancer risk in East Asian women: a collaborative study of 23 637 breast cancer cases and 25 579 controls |
Q24658131 | Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer |
Q34651737 | Common germline genetic variation in antioxidant defense genes and survival after diagnosis of breast cancer |
Q35794653 | Common germline polymorphisms associated with breast cancer-specific survival |
Q45263043 | Common germline polymorphisms in COMT, CYP19A1, ESR1, PGR, SULT1E1 and STS and survival after a diagnosis of breast cancer |
Q34379032 | Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium |
Q73806219 | Common polymorphisms in checkpoint kinase 2 are not associated with breast cancer risk |
Q28237788 | Common polymorphisms in the prostaglandin pathway genes and their association with breast cancer susceptibility and survival |
Q46209474 | Common single-nucleotide polymorphisms in DNA double-strand break repair genes and breast cancer risk |
Q98390794 | Common susceptibility loci for male breast cancer |
Q33947829 | Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers |
Q115209587 | Common variants in breast cancer risk loci predispose to distinct tumor subtypes |
Q57306185 | Common variants in mismatch repair genes and risk of colorectal cancer |
Q35794359 | Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk |
Q21260438 | Common variation in EMSY and risk of breast and ovarian cancer: a case-control study using HapMap tagging SNPs |
Q31082788 | Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
Q42484694 | Comparison of DNA repair protein expression and activities between human fibroblast cell lines with different radiosensitivities |
Q45960056 | Comprehensive association testing of common genetic variation in DNA repair pathway genes in relationship with breast cancer risk in multiple populations. |
Q36026731 | Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer |
Q34181322 | Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer |
Q57278898 | Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
Q45772876 | Correction: Large-Scale Evidence for the Effect of the COLIA1 Sp1 Polymorphism on Osteoporosis Outcomes: The GENOMOS Study |
Q43102129 | Corrigendum: Rare coding variants and X-linked loci associated with age at menarche |
Q101216461 | Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers |
Q58136183 | DNA Polymorphism Studies. Approaches to Elucidating Multifactorial Ischaemic Heart Disease: the Apo B Gene as an Example |
Q47734081 | DNA adducts and lung cancer risk: a prospective study |
Q92762172 | DNA damage and hormone-related cancer: a repair pathway view |
Q57037775 | DNA repair polymorphisms and cancer risk in non-smokers in a cohort study |
Q44212883 | Decreased breast cancer risk in systemic lupus erythematosus: the search for a genetic basis continues |
Q41925653 | Determination of the frequency of the common 657Del5 Nijmegen breakage syndrome mutation in the German population: no association with risk of breast cancer |
Q58546894 | Differential Burden of Rare and Common Variants on Tumor Characteristics, Survival, and Mode of Detection in Breast Cancer |
Q57707723 | Differential Genetic Effects of ESR1 Gene Polymorphisms on Osteoporosis Outcomes |
Q27851413 | Do MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortium |
Q57252081 | Double-strand break DNA repair genotype predictive of later mortality and cancer incidence in a cohort of non-smokers |
Q48769845 | Educational attainment and mean leukocyte telomere length in women in the European Prospective Investigation into Cancer (EPIC)-Norfolk population study. |
Q64387842 | Effect of germ-line genetic variation on breast cancer survival in a population-based study |
Q34778269 | Endometrial cancer and genetic variation in PTEN, PIK3CA, AKT1, MLH1, and MSH2 within a population-based case-control study |
Q33826873 | Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study |
Q57250672 | Erratum: Corrigendum: A common coding variant in CASP8 is associated with breast cancer risk |
Q40556983 | Errors in the polymerase chain reaction |
Q34106703 | Establishment of a Radiogenomics Consortium |
Q98184153 | European polygenic risk score for prediction of breast cancer shows similar performance in Asian women |
Q40238343 | Evaluating genetic variants associated with breast cancer risk in high and moderate-penetrance genes in Asians |
Q35653910 | Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk |
Q36067788 | Evidence of a Causal Association Between Insulinemia and Endometrial Cancer: A Mendelian Randomization Analysis |
Q36720821 | Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors |
Q35064451 | Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation |
Q37342144 | Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation |
Q102215596 | External Validation of a Predictive Model for Acute Skin Radiation Toxicity in the REQUITE Breast Cohort |
Q37594336 | FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium |
Q37323340 | FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation |
Q61560931 | Familial defective apolipoprotein B-100: detection in the United Kingdom and Scandinavia, and clinical characteristics of ten cases |
Q35083710 | Fine mapping of genetic susceptibility loci for melanoma reveals a mixture of single variant and multiple variant regions |
Q37236216 | Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs). |
Q33878276 | Fine scale mapping of the breast cancer 16q12 locus |
Q36111237 | Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus |
Q36856343 | Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression |
Q55380382 | Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression. |
Q35524465 | Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. |
Q61230414 | Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes |
Q92480972 | Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes |
Q55311842 | Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants. |
Q35063160 | Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk |
Q39844032 | Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer |
Q36248936 | Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk |
Q34903062 | Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. |
Q37367871 | Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. |
Q37002930 | Five endometrial cancer risk loci identified through genome-wide association analysis |
Q34979715 | Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium |
Q46943059 | From association to cause: fine mapping of the TNRC9 gene region, a novel susceptibility locus identified in the first genome-wide association study for breast cancer. |
Q38366358 | From candidate gene studies to GWAS and post-GWAS analyses in breast cancer |
Q114182808 | Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element |
Q33629880 | Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148 |
Q36124728 | Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus |
Q34031757 | Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers |
Q36742577 | Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers |
Q40137431 | Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium |
Q59138862 | Genetic Predictors of Normal Tissue Response to Radiotherapy |
Q37389405 | Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer |
Q115209620 | Genetic analyses of gynecological disease identify genetic relationships between uterine fibroids and endometrial cancer, and a novel endometrial cancer genetic risk region at the WNT4 1p36.12 locus |
Q41687339 | Genetic evidence that the putative receptor binding domain of apolipoprotein B (residues 3130 to 3630) is not the only region of the protein involved in interaction with the low density lipoprotein receptor |
Q108609948 | Genetic insights into biological mechanisms governing human ovarian ageing |
Q37739048 | Genetic modifiers of CHEK2*1100delC-associated breast cancer risk |
Q54940815 | Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses. |
Q35925620 | Genetic predisposition to ductal carcinoma in situ of the breast |
Q35151684 | Genetic predisposition to in situ and invasive lobular carcinoma of the breast |
Q52430637 | Genetic relationship between the 3'-VNTR and diallelic apolipoprotein B gene polymorphisms: haplotype analysis in individuals of European and south Asian origin |
Q57252090 | Genetic susceptibility according to three metabolic pathways in cancers of the lung and bladder and in myeloid leukemias in nonsmokers |
Q28481918 | Genetic variants in ER cofactor genes and endometrial cancer risk |
Q34497690 | Genetic variants in epigenetic genes and breast cancer risk. |
Q35022825 | Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers |
Q35179897 | Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study |
Q46750307 | Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women |
Q34038369 | Genetic variation in SIPA1 in relation to breast cancer risk and survival after breast cancer diagnosis |
Q34378972 | Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade |
Q37131328 | Genetic variation in stromal proteins decorin and lumican with breast cancer: investigations in two case-control studies |
Q24811147 | Genetic variation in the HSD17B1 gene and risk of prostate cancer |
Q37311599 | Genetic variation in the chromosome 17q23 amplicon and breast cancer risk |
Q36422109 | Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium |
Q28388497 | Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types |
Q36842233 | Genome-wide association analysis identifies three new breast cancer susceptibility loci |
Q35996692 | Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer |
Q63681757 | Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer |
Q93270780 | Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility |
Q37990107 | Genome-wide association studies and prediction of normal tissue toxicity |
Q24622610 | Genome-wide association studies identify four ER negative-specific breast cancer risk loci |
Q95329367 | Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses |
Q29417135 | Genome-wide association study identifies a common variant associated with risk of endometrial cancer |
Q29417050 | Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk |
Q36024614 | Genome-wide association study identifies a possible susceptibility locus for endometrial cancer |
Q34114293 | Genome-wide association study identifies five new breast cancer susceptibility loci |
Q24645441 | Genome-wide association study identifies novel breast cancer susceptibility loci |
Q52720511 | Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia. |
Q29416994 | Genome-wide association study identifies three new melanoma susceptibility loci |
Q59795648 | Genome-wide association study implicates immune dysfunction in the development of Hodgkin lymphoma |
Q27008356 | Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk |
Q47125417 | Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility |
Q28660394 | Genome-wide association study of endometrial cancer in E2C2 |
Q64040390 | Genome-wide association study of germline variants and breast cancer-specific mortality |
Q36019187 | Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma |
Q59566871 | Genomic analyses for age at menarche identify 389 independent signals and indicate BMI-independent effects of puberty timing on cancer susceptibility |
Q38823212 | Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk |
Q47552886 | Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study |
Q96432094 | Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk |
Q35798435 | Germline TERT promoter mutations are rare in familial melanoma |
Q57266937 | Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlation |
Q114182677 | Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis |
Q34014453 | HSD17B1 genetic variants and hormone receptor-defined breast cancer |
Q36612585 | HapMap-based study of the 17q21 ERBB2 amplicon in susceptibility to breast cancer |
Q36276540 | Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization |
Q33330850 | Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics |
Q119213179 | High-throughput allelic expression imbalance analyses identify candidate breast cancer risk genes |
Q28303249 | Hyaluronan-mediated motility receptor gene single nucleotide polymorphisms and risk of breast cancer |
Q57202722 | IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer |
Q35102646 | Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk |
Q39182862 | Identification of 19 new risk loci and potential regulatory mechanisms influencing susceptibility to testicular germ cell tumor |
Q29417155 | Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array |
Q36720814 | Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk |
Q36618927 | Identification of a C/G polymorphism in the promoter region of the BRCA1 gene and its use as a marker for rapid detection of promoter deletions |
Q24653491 | Identification of common variants in the SHBG gene affecting sex hormone-binding globulin levels and breast cancer risk in postmenopausal women |
Q36859142 | Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer |
Q40648445 | Identification of genetic variation that determines levels of plasma triglycerides and hypercoagulability |
Q36086247 | Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus |
Q58743933 | Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma |
Q34038964 | Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions |
Q57170142 | Identification of nine new susceptibility loci for endometrial cancer |
Q90091185 | Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants |
Q36014067 | Identification of novel genetic markers of breast cancer survival |
Q46103372 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer |
Q57202710 | Implications of Gene-Environment Interaction in Studies of Gene Variants in Breast Cancer: An Example of Dietary Isoflavones and the D356N Polymorphism in theSex Hormone-Binding GlobulinGene: Figure 1 |
Q38545794 | Incorporating Genetic Biomarkers into Predictive Models of Normal Tissue Toxicity |
Q114184688 | Incorporating progesterone receptor expression into the PREDICT breast prognostic model |
Q34240634 | Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study |
Q31116483 | Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients |
Q34314677 | Individual patient data meta-analysis shows no association between the SNP rs1800469 in TGFB and late radiotherapy toxicity. |
Q47586106 | Inherited mutations in BRCA1 and BRCA2 in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from Malaysia |
Q35104068 | Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer |
Q24652651 | Interactions between genes involved in the antioxidant defence system and breast cancer risk |
Q34898735 | Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors |
Q41320578 | Is Southern blotting necessary to measure telomere length reproducibly? Authors' Response to: Commentary: The reliability of telomere length measurements |
Q47190168 | Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium |
Q57191573 | Large-Scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility, and BRCA1-Mediated DNA Repair |
Q62583667 | Large-scale Analysis Demonstrates Familial Testicular Cancer to have Polygenic Aetiology |
Q40122475 | Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS study |
Q38730359 | Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes |
Q24288773 | Large-scale evidence for the effect of the COLIA1 Sp1 polymorphism on osteoporosis outcomes: the GENOMOS study |
Q28267893 | Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair |
Q29416989 | Large-scale genotyping identifies 41 new loci associated with breast cancer risk |
Q50793046 | Life stress, emotional health, and mean telomere length in the European Prospective Investigation into Cancer (EPIC)-Norfolk population study. |
Q33896984 | Longer polyglutamine tracts in the androgen receptor are associated with moderate to severe undermasculinized genitalia in XY males |
Q35119701 | Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium |
Q34700093 | Lymphocyte telomere length is long in BRCA1 and BRCA2 mutation carriers regardless of cancer-affected status |
Q115161239 | Marital status and prostate cancer incidence: a pooled analysis of 12 case–control studies from the PRACTICAL consortium |
Q114182490 | Mendelian randomisation study of smoking exposure in relation to breast cancer risk |
Q98772941 | Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer |
Q37283218 | Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer |
Q36333368 | Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1. |
Q63352621 | Meta-analysis of up to 622,409 individuals identifies 40 novel smoking behaviour associated genetic loci |
Q36180915 | Methodology of laboratory measurements in prospective studies on gene-environment interactions: the experience of GenAir |
Q34497352 | MicroRNA related polymorphisms and breast cancer risk |
Q34123806 | Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls |
Q34736858 | Most common 'sporadic' cancers have a significant germline genetic component |
Q53342282 | Multi-factor dimensionality reduction applied to a large prospective investigation on gene-gene and gene-environment interactions. |
Q36897003 | Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer |
Q33988405 | Multiple loci with different cancer specificities within the 8q24 gene desert |
Q37356243 | Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. |
Q34057961 | No association between FTO or HHEX and endometrial cancer risk |
Q35061078 | No association between SNPs regulating TGF-β1 secretion and late radiotherapy toxicity to the breast: results from the RAPPER study |
Q33982873 | No association between TERT-CLPTM1L single nucleotide polymorphism rs401681 and mean telomere length or cancer risk |
Q36292769 | No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer |
Q53417363 | No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancer. |
Q30374367 | No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. |
Q37079859 | No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing |
Q92476025 | Non-coding RNAs underlie genetic predisposition to breast cancer |
Q37162103 | Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype |
Q35752042 | Novel Associations between Common Breast Cancer Susceptibility Variants and Risk-Predicting Mammographic Density Measures |
Q28584533 | PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS |
Q47143943 | PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1. |
Q24563091 | POT1 loss-of-function variants predispose to familial melanoma |
Q57315735 | PROTEIN-CODING VARIANTS IMPLICATE NOVEL GENES RELATED TO LIPID HOMEOSTASIS CONTRIBUTING TO BODY FAT DISTRIBUTION |
Q34289136 | Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche |
Q99408631 | Pathogenic Variants in CHEK2 Are Associated With an Adverse Prognosis in Symptomatic Early-Onset Breast Cancer |
Q112572520 | Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes |
Q37307937 | Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association Consortium |
Q36574725 | Patients with a High Polygenic Risk of Breast Cancer do not have An Increased Risk of Radiotherapy Toxicity |
Q57306160 | Phytoestrogen Exposure Is Associated with Circulating Sex Hormone Levels in Postmenopausal Women and Interact with ESR1 and NR1I2 Gene Variants |
Q57202732 | Phytoestrogen Exposure, Polymorphisms in COMT, CYP19, ESR1, and SHBG Genes, and Their Associations With Prostate Cancer Risk |
Q45236801 | Phytoestrogen exposure correlation with plasma estradiol in postmenopausal women in European Prospective Investigation of Cancer and Nutrition-Norfolk may involve diet-gene interactions. |
Q57306194 | Polygenic Inherited Predisposition to Breast Cancer |
Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
Q44938215 | Polymorphisms associated with circulating sex hormone levels in postmenopausal women |
Q43792195 | Polymorphisms in CYP1A1 and smoking: no association with breast cancer risk |
Q57306195 | Polymorphisms in DNA repair genes and epithelial ovarian cancer risk |
Q36066735 | Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression |
Q36915870 | Polymorphisms in inflammation pathway genes and endometrial cancer risk |
Q57202739 | Polymorphisms in the CYP19 gene may affect the positive correlations between serum and urine phytoestrogen metabolites and plasma androgen concentrations in men |
Q53414081 | Polymorphisms in the human aromatase cytochrome P450 gene (CYP19) and breast cancer risk. |
Q40386919 | Polymorphisms in the initiators of RET (rearranged during transfection) signaling pathway and susceptibility to sporadic medullary thyroid carcinoma |
Q95318005 | Population Study of Ovarian Cancer Risk Prediction for Targeted Screening and Prevention |
Q92055460 | Prediction and clinical utility of a contralateral breast cancer risk model |
Q37487782 | Prediction of breast cancer risk based on common genetic variants in women of East Asian ancestry |
Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
Q91832507 | Prediction of contralateral breast cancer: external validation of risk calculators in 20 international cohorts |
Q62583372 | Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort |
Q35018327 | Progesterone receptor gene variants and risk of endometrial cancer |
Q37318149 | Prognostic value of PAI1 in invasive breast cancer: evidence that tumor-specific factors are more important than genetic variation in regulating PAI1 expression |
Q35193839 | Prospective study of insulin-like growth factor-I, insulin-like growth factor-binding protein 3, genetic variants in the IGF1 and IGFBP3 genes and risk of coronary artery disease. |
Q47177885 | Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity |
Q62839973 | Protein-coding variants implicate novel genes related to lipid homeostasis contributing to body-fat distribution |
Q55508030 | Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. |
Q92503516 | Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity |
Q51762287 | Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity. |
Q51779676 | Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity. |
Q90242034 | Publisher Correction: Shared heritability and functional enrichment across six solid cancers |
Q88214332 | Publisher correction: Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148 |
Q46003133 | Quantitative analysis of DNA methylation after whole bisulfitome amplification of a minute amount of DNA from body fluids. |
Q36009422 | RAD51B in Familial Breast Cancer |
Q92122426 | RAPPER - A Success Story for Collaborative Translational Radiotherapy Research |
Q57306176 | RAPPER: The Radiogenomics of Radiation Toxicity |
Q92406757 | REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer |
Q57306197 | RESPONSE: Re: Polymorphisms Associated With Circulating Sex Hormone Levels in Postmenopausal Women |
Q64108927 | Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy |
Q92633443 | Radiogenomics in the Era of Advanced Radiotherapy |
Q30833608 | Radiogenomics: radiobiology enters the era of big data and team science |
Q38294605 | Radiogenomics: the search for genetic predictors of radiotherapy response |
Q57306190 | Radiosensitivity, Radiogenomics and RAPPER |
Q29583867 | Rare and low-frequency coding variants alter human adult height |
Q35961979 | Rare coding variants and X-linked loci associated with age at menarche |
Q51102391 | Rare germline copy number deletions of likely functional importance are implicated in endometrial cancer predisposition. |
Q114182625 | Rare germline copy number variants (CNVs) and breast cancer risk |
Q40094101 | Rare, protein-truncating variants in ATM, CHEK2 and PALB2, but not XRCC2, are associated with increased breast cancer risks |
Q35741115 | Rat Mcs5a is a compound quantitative trait locus with orthologous human loci that associate with breast cancer risk |
Q24794752 | Red-clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial [ISRCTN42940165] |
Q35155449 | Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia |
Q69024652 | Relationships between DNA and protein polymorphisms of apolipoprotein B |
Q48943031 | Reproducibility of Telomere Length Assessment--An International Collaborative Study. |
Q49111171 | Reproducibility of telomere length assessment: Authors' Response to Damjan Krstajic and Ljubomir Buturovic. |
Q41935897 | Reproducibility of telomere length assessment: an international collaborative study |
Q37300024 | Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. |
Q46776482 | Role of CHEK2*1100delC in unselected series of non-BRCA1/2 male breast cancers |
Q91918447 | Runs of homozygosity and testicular cancer risk |
Q36545934 | SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival |
Q36672778 | STROGAR - STrengthening the Reporting Of Genetic Association studies in Radiogenomics |
Q36397260 | Saliva samples are a viable alternative to blood samples as a source of DNA for high throughput genotyping |
Q44086012 | Sampling distribution of summary linkage disequilibrium measures |
Q33467087 | Seq4SNPs: new software for retrieval of multiple, accurately annotated DNA sequences, ready formatted for SNP assay design |
Q57271433 | Sequence Variants of Estrogen Receptor and Risk of Prostate Cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium |
Q61118451 | Shared heritability and functional enrichment across six solid cancers |
Q64004349 | Shared heritability and functional enrichment across six solid cancers |
Q21135356 | Shortened telomere length is associated with increased risk of cancer: a meta-analysis |
Q36614423 | Single-nucleotide polymorphisms in the RB1 gene and association with breast cancer in the British population |
Q36835706 | Somatically acquired hypomethylation of IGF2 in breast and colorectal cancer |
Q33909674 | Standardized Total Average Toxicity score: a scale- and grade-independent measure of late radiotherapy toxicity to facilitate pooling of data from different studies |
Q33593016 | Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies |
Q35038651 | TGF-β signaling pathway and breast cancer susceptibility |
Q33566957 | TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer |
Q57037815 | TP53andKRAS2Mutations in Plasma DNA of Healthy Subjects and Subsequent Cancer Occurrence: A Prospective Study |
Q33277172 | Tagging single nucleotide polymorphisms in the BRIP1 gene and susceptibility to breast and ovarian cancer |
Q34486210 | Tagging single-nucleotide polymorphisms in antioxidant defense enzymes and susceptibility to breast cancer |
Q91044035 | Targeted Resequencing of the Coding Sequence of 38 Genes Near Breast Cancer GWAS Loci in a Large Case-Control Study |
Q35698038 | Telomere length and common disease: study design and analytical challenges |
Q33794700 | Telomere length in prospective and retrospective cancer case-control studies |
Q49817640 | The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity. |
Q33300099 | The CASP8 -652 6N del promoter polymorphism and breast cancer risk: a multicenter study |
Q91178389 | The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer |
Q37578078 | The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers |
Q57306198 | The Reliable Identification of Disease-Gene Associations |
Q41206198 | The amino terminus of apolipoprotein B is necessary but not sufficient for microsomal triglyceride transfer protein responsiveness |
Q34569981 | The association between common vitamin D receptor gene variations and osteoporosis: a participant-level meta-analysis |
Q34333988 | The effect on melanoma risk of genes previously associated with telomere length |
Q34144358 | The extent of linkage disequilibrium in four populations with distinct demographic histories |
Q64998464 | The functional ALDH2 polymorphism is associated with breast cancer risk: A pooled analysis from the Breast Cancer Association Consortium. |
Q93054131 | The genetic interplay between body mass index, breast size and breast cancer risk: a Mendelian randomization analysis |
Q29614700 | The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups |
Q54796500 | The patched polymorphism Pro1315Leu (C3944T) may modulate the association between use of oral contraceptives and breast cancer risk. |
Q36142060 | The role of genetic breast cancer susceptibility variants as prognostic factors |
Q46364450 | The search for low-penetrance breast cancer genes. |
Q114677146 | Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction |
Q89961489 | Transcriptome-wide association study of breast cancer risk by estrogen-receptor status |
Q35195246 | Two amino acid substitutions in apolipoprotein B are in complete allelic association with the antigen group (x/y) polymorphism: evidence for little recombination in the 3' end of the human gene |
Q92994868 | Two truncating variants in FANCC and breast cancer risk |
Q115601277 | Uncovering the Contribution of Moderate-Penetrance Susceptibility Genes to Breast Cancer by Whole-Exome Sequencing and Targeted Enrichment Sequencing of Candidate Genes in Women of European Ancestry |
Q48346921 | Unequal crossing-over between two alu-repetitive DNA sequences in the low-density-lipoprotein-receptor gene. A possible mechanism for the defect in a patient with familial hypercholesterolaemia |
Q50084544 | Use of deep whole genome sequencing data to identify structure risk variants in breast cancer susceptibility genes. |
Q52725335 | Validation of loci at 2q14.2 and 15q21.3 as risk factors for testicular cancer. |
Q57725761 | Validation of the prognostic value of percentage total plaque score normalised to age on coronary computed tomography |
Q34129771 | Variants in DNA double-strand break repair genes and breast cancer susceptibility |
Q41672002 | XRCC1 Polymorphism Associated With Late Toxicity After Radiation Therapy in Breast Cancer Patients |
Q37414133 | rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk |
Search more.